ICU MEDICAL INC/DE

For the period ended Sep 30, 2026. Filed Nov 5, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Nov 5, 2026

ICUI$182.11+1.8%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Balance Sheets at and

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except par value data and treasury shares)

September 30,2026 · December 31,2025
	(Unaudited)	(1)
ASSETS
CURRENT ASSETS:
Cash and cash equivalents	$301,780		$307,963
Accounts receivable, net of allowance of $13,751 at September 30, 2026 and $14,383 at December 31, 2025	206,258		180,515
Inventories	607,268		615,859
Prepaid expenses and other current assets	104,559		86,217
TOTAL CURRENT ASSETS	1,219,865		1,190,554
PROPERTY, PLANT AND EQUIPMENT, net	444,991		451,817
OPERATING LEASE RIGHT-OF-USE ASSETS	36,170		54,470
GOODWILL	1,482,783		1,499,754
INTANGIBLE ASSETS, net	536,466		633,559
DEFERRED INCOME TAXES	25,437		25,891
OTHER ASSETS	69,161		62,877
INVESTMENTS IN UNCONSOLIDATED AFFILIATES	128,929		131,586
TOTAL ASSETS	$3,943,802		$4,050,508
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES:
Accounts payable	$142,989		$154,374
Accrued liabilities	342,805		315,337
Current portion of long-term debt	18,750		18,750
Income tax payable	10,089		10,400
TOTAL CURRENT LIABILITIES	514,633		498,861
LONG-TERM DEBT	1,133,096		1,265,917
OTHER LONG-TERM LIABILITIES	68,969		89,536
DEFERRED INCOME TAXES	8,764		37,756
INCOME TAX LIABILITY	26,922		34,613
COMMITMENTS AND CONTINGENCIES (Note 20)
STOCKHOLDERS’ EQUITY:
Convertible preferred stock, $1.00 par value; Authorized — 500 shares; Issued and outstanding — none	—		—
Common stock, $0.10 par value; Authorized — 80,000 shares; Issued — 25,186 shares at September 30, 2026 and 24,688 shares at December 31, 2025; and outstanding — 25,010 shares at September 30, 2026 and 24,688 shares at December 31, 2025	2,519		2,469
Additional paid-in capital	1,487,156		1,465,118
Treasury stock, at cost 176,327 shares at September 30, 2026 and 172 shares at December 31, 2025)	(23,040)		(22)
Retained earnings	766,956		690,890
Accumulated other comprehensive loss	(42,173)		(34,630)
TOTAL STOCKHOLDERS' EQUITY	2,191,418		2,123,825
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$3,943,802		$4,050,508

(1)December 31, 2025 balances were derived from audited consolidated financial statements.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.